The National Institute of Allergy and Infectious Diseases has awarded funding to KU Molecular Bioscience faculty to research Herpes simplex virus (HVS-1) with the goal of restricting viral replication.
https://t.co/qKZpoY3Dfs @KUMolBio
KU research funding helps support nearly 5,600 jobs in the state.
People in these jobs live in Kansas, patronize local businesses, and contribute tax dollars that support public services.
Read more about @UnivOfKansas research impact. ⬇️
https://t.co/KqvZzA8KHV
#KUForKansas
A new @KUMolBio study details the vulnerability of coronaviruses to inhibitors of a small protein domain found in all coronaviruses.
The findings point toward potential antiviral therapies to combat future coronavirus pandemics.
https://t.co/v9z67nPdPG
Great to hear from some Hefty lab/KU alumni!! Justin Massey, Adian Dmitriev, and Melissa Berger - best of luck and keep excelling in public health/Science!
Scott Lovell is studying proteins that could lead to new types of antibiotics.
Learn more about the @UnivOfKansas core lab director's work in the video below.
https://t.co/sBu4GELRJJ
Research funded in part by @NIH led @UnivOfKansas scientists and colleagues to a discovery that points toward potential antiviral therapies to combat future coronavirus pandemics. The findings appear in @mbiojournal.
Last visit of the trip at Maria Nuova Hospital which is the oldest active hospital in the world built in the 1600’s, renowned for medical innovation, renaissance art, historical architecture, and its continued role in modern healthcare.